keyword
https://read.qxmd.com/read/38652565/renal-cell-carcinoma-histologic-subtypes-exhibit-distinct-transcriptional-profiles
#1
JOURNAL ARTICLE
Pedro Barata, Shuchi Gulati, Andrew Elliott, Hans J Hammers, Earle F Burgess, Benjamin A Gartrell, Sourat Darabi, Mehmet A Bilen, Arnab Basu, Daniel M Geynisman, Nancy A Dawson, Matthew R Zibelman, Tian Zhang, Shuanzeng Wei, Charles J Ryan, Elisabeth I Heath, Kelsey A Poorman, Chadi Nabhan, Rana R McKay
Molecular profiling of clear cell RCC (ccRCC) tumors of clinical trial patients has identified distinct transcriptomic signatures with predictive value, yet data in non-clear cell variants (nccRCC) are lacking. We examined the transcriptional profiles of RCC tumors representing key molecular pathways, from a multi-institutional, real-world patient cohort, including ccRCC (n = 508) and centrally-reviewed nccRCC (n = 149) samples. ccRCC had increased angiogenesis signature scores compared to the heterogeneous group of nccRCC tumors (mean z-score 0...
April 23, 2024: Journal of Clinical Investigation
https://read.qxmd.com/read/38652547/multi-omics-characterization-of-esophageal-squamous-cell-carcinoma-identifies-molecular-subtypes-and-therapeutic-targets
#2
JOURNAL ARTICLE
Dengyun Zhao, Yaping Guo, Huifang Wei, Xuechao Jia, Yafei Zhi, Guiliang He, Wenna Nie, Limeng Huang, Penglei Wang, Kyle Vaughn Laster, Zhicai Liu, Jinwu Wang, Mee-Hyun Lee, Zigang Dong, Kangdong Liu
Esophageal squamous cell carcinoma (ESCC) is the predominant form of esophageal cancer and is characterized by an unfavorable prognosis. To elucidate the distinct molecular alterations in ESCC and investigate therapeutic targets, we performed a comprehensive analysis of transcriptomic, proteomic, and phosphoproteomic data derived from 60 paired treatment-naive ESCC and adjacent non-tumor tissue samples. Additionally, we conducted a correlation analysis to describe the regulatory relationship between transcriptomic and proteomic processes, revealing alterations in key metabolic pathways...
April 23, 2024: JCI Insight
https://read.qxmd.com/read/38652311/the-landsteiner-lung-cancer-research-platform-laluca-objectives-methodology-and-implementation-of-a%C3%A2-real-world-clinical-lung-cancer-registry
#3
JOURNAL ARTICLE
Anna Lang-Stöberl, Hannah Fabikan, Maximilan Hochmair, Klaus Kirchbacher, Vikaela Mania Rodriguez, Leya Ay, Christoph Weinlinger, David Rosenthaler, Oliver Illini, Nino Müser, Georg-Christian Funk, Arschang Valipour
BACKGROUND: Lung cancer is a major health burden in Austria; however, limited real-world data exist on the diagnostic and treatment reality of lung cancer patients in Austria. The collection of high-quality data in a clinical setting is needed to gain insights into the real-world diagnostic and therapeutic management of lung cancer patients. METHODS: The Karl Landsteiner Institute for Lung Research and Pulmonary Oncology implemented the Landsteiner lung cancer research platform (LALUCA), recruiting unselected lung cancer patients from two high volume centers in Vienna...
April 23, 2024: Wiener Klinische Wochenschrift
https://read.qxmd.com/read/38652307/-precision-oncology-and-molecular-tumor-boards
#4
JOURNAL ARTICLE
Elisabeth Mack, Peter Horak, Stefan Fröhling, Andreas Neubauer
Precision oncology is a field of personalized medicine in which tumor biology forms the basis for tailored treatments. The preferred approach currently applied in clinical practice is based on the concept of malignant tumors as genetic diseases that are caused by mutations in oncogenes and tumor suppressors. On the one hand, these can be targeted by molecular drugs, while on the other hand, next-generation sequencing allows for comprehensive analysis of all relevant aberrations, thus enabling the matching of appropriate treatments across entities based on molecular information...
April 23, 2024: Inn Med (Heidelb)
https://read.qxmd.com/read/38652138/dynamic-simulations-of-interaction-of-the-peg-dppe-micelle-encapsulated-short-chain-ceramides-with-the-raft-included-membrane
#5
JOURNAL ARTICLE
Lina Zhao, Yanjiao Wang, Yi Zhang, Hao Chen, Fude Sun
The lipid raft subdomains in cancer cell membranes play a key role in signal transduction, biomolecule recruitment, and drug transmembrane transport. Augmented membrane rigidity due to the formation of a lipid raft is unfavorable for the entry of drugs, a limiting factor in clinical oncology. The short-chain ceramide (CER) has been reported to promote drug entry into membranes and disrupt lipid raft formation, but the underlying mechanism is not well understood. We recently explored the carrier-membrane fusion dynamics of PEG-DPPE micelles in delivering doxorubicin (DOX)...
April 23, 2024: Journal of Chemical Information and Modeling
https://read.qxmd.com/read/38652115/interplay-of-precision-therapeutics-and-md-study-calocybe-indica-s-potentials-against-cervical-cancer-and-its-interaction-with-vegf-via-octadecanoic-acid
#6
JOURNAL ARTICLE
Suhana Datta, Preeti Verma, Bikram Dhara, Rita Kundu, Swastika Maitra, Arup Kumar Mitra, Mohd Shahnawaz Khan, Torki A Zughaibi, Shams Tabrez, Ajoy Kumer
The evolving landscape of personalized medicine necessitates a shift from traditional therapeutic interventions towards precision-driven approaches. Embracing this paradigm, our research probes the therapeutic efficacy of the aqueous crude extract (ACE) of Calocybe indica in cervical cancer treatment, merging botanical insights with advanced molecular research. We observed that ACE exerts significant influences on nuclear morphology and cell cycle modulation, further inducing early apoptosis and showcasing prebiotic attributes...
April 2024: Journal of Cellular and Molecular Medicine
https://read.qxmd.com/read/38652054/car-t-therapy-followed-by-hematopoietic-stem-cell-transplantation-can-improve-survival-in-children-relapsed-refractory-philadelphia-chromosome-positive-b-cell-acute-lymphoblastic-leukemia
#7
JOURNAL ARTICLE
Yao Li, Guan-Hua Hu, Lan-Ping Xu, Xiao-Hui Zhang, Kai-Yan Liu, Pan Suo, Yu Wang, Yi-Fei Cheng, Xiao-Jun Huang
BACKGROUND: Philadelphia chromosome (Ph)-positive B-cell acute lymphoblastic leukemia (ALL) has a high complete remission (CR) rate, but relapse and prolonged measurable residual disease remain serious problems. We sought to describe the CR rate measurable residual disease negative rate and address the results and safety of pediatric patients who underwent after receiving chimeric antigen receptor (CAR) specific for CD19 (CAR-19) followed by hematopoietic stem cell transplantation (HSCT) for the treatment of Ph-positive ALL...
April 23, 2024: Journal of Pediatric Hematology/oncology
https://read.qxmd.com/read/38652041/regulatory-role-of-cd39-and-cd73-in-tumor-immunity
#8
REVIEW
Nicole Kaplinsky, Kada Williams, Dean Watkins, Molly Adams, Laura Stanbery, John Nemunaitis
CD39 is the rate-limiting enzyme for the molecular signal cascade leading to the generation of ADP and adenosine monophosphate (AMP). In conjunction with CD73, CD39 converts adenosine triphosphate (ATP) to ADP and AMP, which leads to the accumulation of immunosuppressive adenosine in the tumor microenvironment. This review focuses on the role of CD39 and CD73 in immune response and malignant progression, including the expression of CD39 within the tumor microenvironment and its relationship to immune effector cells, and its role in antigen presentation...
April 23, 2024: Future Oncology
https://read.qxmd.com/read/38651727/genomic-and-transcriptomic-landscape-of-ret-wild-type-medullary-thyroid-cancer-and-potential-use-of-mitogen-activated-protein-kinase-targeted-therapy
#9
JOURNAL ARTICLE
Sourat Darabi, Tolulope Adeyelu, Andrew Elliott, Ammar Sukari, Kurt Hodges, Farah Abdulla, Carlos E Zuazo, Trisha Wise-Draper, Thomas Wang, Michael J Demeure
BACKGROUND: About 75% of medullary thyroid cancers (MTCs) are sporadic with 45-70% being driven by a RET mutation. Selpercatinib is an approved treatment for RET-mutated (mutRET) MTC, however, treatments are needed for wild-type RET MTC (wtRET). Genomic alterations and transcriptomic signatures of wtRET MTC may reveal new therapeutic insights. METHODS: We did a retrospective analysis of MTC samples submitted for DNA/RNA sequencing and PD-L1 expression using IHC at a CLIA/CAP-certified lab...
April 23, 2024: Journal of the American College of Surgeons
https://read.qxmd.com/read/38651158/diagnostic-value-of-one-step-nucleic-acid-amplification-for-sentinel-lymph-node-metastasis-in-cytokeratin-19-positive-tumors-evidence-from-bioinformatics-and-meta-analysis
#10
Ke Li, Min Meng, Weiwei Zhang, Junyi Li, Yiting Wang, Changhui Zhou
BACKGROUND: The status of the sentinel lymph nodes (SLNs) was an important prognostic factor in varies cancers. A one-step nucleic acid amplification (OSNA) assay, a molecular-based whole-node analysis method based on CK19 mRNA copy number, was developed to diagnose lymph node metastases. We aimed to evaluate the value of OSNA for the diagnosis of sentinel lymph node metastasis in CK19 positive cancers. CK19 mRNA and protein expression for pan-caner analysis were obtained from TCGA and the Human protein atlas database...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38651154/case-report-salivary-duct-carcinoma-in-a-patient-with-a-germline-cdh1-pathogenic-variant-expanding-the-spectrum-of-hereditary-cancer-predisposition-syndromes
#11
Nidhi Desai, Emilian Racila, Naomi Fujioka, Arjun Gupta, Emmanuel S Antonarakis
INTRODUCTION: Recently, an entity known as salivary duct carcinoma with rhabdoid features (SDC-RF) has been associated with somatic CDH1 mutations. Here we present the first known case report of conventional SDC occurring in the setting of a germline CDH1 pathogenic variant accompanied by a somatic loss of heterozygosity at the CDH1 locus. CASE DISCUSSION: A 67-year-old man presented with chest and back pain and was found to have osteolytic lesions in the sternum and lumbar spine...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38651144/potential-role-of-the-eph-ephrin-system-in-colorectal-cancer-emerging-druggable-molecular-targets
#12
REVIEW
João Figueira Scarini, Moisés Willian Aparecido Gonçalves, Reydson Alcides de Lima-Souza, Luccas Lavareze, Talita de Carvalho Kimura, Ching-Chu Yang, Albina Altemani, Fernanda Viviane Mariano, Heloisa Prado Soares, Gary Chris Fillmore, Erika Said Abu Egal
The Eph/ephrin system regulates many developmental processes and adult tissue homeostasis. In colorectal cancer (CRC), it is involved in different processes including tumorigenesis, tumor angiogenesis, metastasis development, and cancer stem cell regeneration. However, conflicting data regarding Eph receptors in CRC, especially in its putative role as an oncogene or a suppressor gene, make the precise role of Eph-ephrin interaction confusing in CRC development. In this review, we provide an overview of the literature and highlight evidence that collaborates with these ambiguous roles of the Eph/ephrin system in CRC, as well as the molecular findings that represent promising therapeutic targets...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38651061/bioinformatics-analysis-and-experimental-verification-of-tigd1-in-non-small-cell-lung-cancer
#13
JOURNAL ARTICLE
Lingchun Xia, Zhuofan Yang, Mingming Xv, Guohui Wang, Yaxin Mao, Yihan Yang, Jian Tang
INTRODUCTION: Non-small cell lung cancer (NSCLC) is a prevalent respiratory system tumor. Triggered transposable element derivative 1 (TIGD1) exhibits significant overexpression in various tumor cells and tissues, suggesting its involvement in cancer progression. METHODS: Clinical data and gene expression profiles of lung adenocarcinoma were collected from TCGA, UCSC XENA, and GEO databases. Computational techniques and empirical studies were employed to analyze the role of TIGD1 in NSCLC...
2024: Frontiers in Medicine
https://read.qxmd.com/read/38650175/kinase-activities-in-pancreatic-ductal-adenocarcinoma-with-prognostic-and-therapeutic-avenues
#14
JOURNAL ARTICLE
Andrea Vallés-Martí, Richard R de Goeij-de Haas, Alex A Henneman, Sander R Piersma, Thang V Pham, Jaco C Knol, Joanne Verheij, Frederike Dijk, Hans Halfwerk, Elisa Giovannetti, Connie R Jiménez, Maarten F Bijlsma
Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with a limited number of known driver mutations but considerable cancer cell heterogeneity. Phosphoproteomics provides a direct read-out of aberrant signaling and the resultant clinically relevant phenotype. Mass spectrometry (MS)-based proteomics and phosphoproteomics were applied to 42 PDAC tumors. Data encompassed over 19 936 phosphoserine or phosphothreonine (pS/T; in 5412 phosphoproteins) and 1208 phosphotyrosine (pY; in 501 phosphoproteins) sites and a total of 3756 proteins...
April 22, 2024: Molecular Oncology
https://read.qxmd.com/read/38649649/slicerpit-software-development-and-implementation-for-planning-and-image-guided-therapy-in-photoimmunotherapy
#15
JOURNAL ARTICLE
Takayoshi Suzuki, Satoshi Kano, Masanobu Suzuki, Seijiro Hamada, Hiroshi Idogawa, Nayuta Tsushima, Yuichi Ashikaga, Yuki Wakabayashi, Takeshi Soyama, Yasuhiro Hida, Akihiro Homma
BACKGROUND: Photoimmunotherapy is a treatment modality that induces targeted cell death by binding a molecular-targeted drug activated by infrared light to the tumor cells and subsequently illuminating the lesion with infrared light. For deep lesions, a needle catheter is used to puncture the tumor, and an illumination fiber (cylindrical diffuser) is inserted into the catheter lumen for internal illumination. However, it can be challenging to place the cylindrical diffusers in an appropriate position as the deep lesions cannot be often confirmed accurately during surgery...
April 23, 2024: International Journal of Clinical Oncology
https://read.qxmd.com/read/38648188/bringing-the-genomic-revolution-to-comparative-oncology-human-and-dog-cancers
#16
REVIEW
James A Cahill, Leslie A Smith, Soumya Gottipati, Tina Salehi Torabi, Kiley Graim
Dogs are humanity's oldest friend, the first species we domesticated 20,000-40,000 years ago. In this unequaled collaboration, dogs have inadvertently but serendipitously been molded into a potent human cancer model. Unlike many common model species, dogs are raised in the same environment as humans and present with spontaneous tumors with human-like comorbidities, immunocompetency, and heterogeneity. In breast, bladder, blood, and several pediatric cancers, in-depth profiling of dog and human tumors has established the benefits of the dog model...
April 22, 2024: Annual review of biomedical data science
https://read.qxmd.com/read/38647874/biomarker-oriented-chemo-immunotherapy-for-advanced-gastric-cancer
#17
REVIEW
Koji Kono, Shotaro Nakajima, Kosaku Mimura
The biomarker-oriented chemo-immunotherapy is useful and promising in the development of new anticancer agents, since the responders can be enriched by selecting patients with biomarkers. Compared to colorectal and lung cancers, the development of biomarker-driven molecular-targeted therapeutics for gastric cancers has been straggled. However, several new biomarkers in gastric cancers have been discovered and clinical trials in enrichment design with certain biomarkers have been conducted. Therefore, there are currently several treatment options to treat gastric cancer patients based on individual biomarker-oriented strategies...
April 22, 2024: International Journal of Clinical Oncology
https://read.qxmd.com/read/38647375/y-chromosome-loss-and-implications-for-oncology
#18
JOURNAL ARTICLE
Canan D Dirican, Peter S Nelson
The Y chromosome has recognized functions in promoting male sex determination and regulating aspects of fertility. However, recent work has demonstrated important roles for the Y chromosome and Y-encoded genes in multiple domains of male health, including cancer. It is well-established that males experience shorter life spans than females, and this sex bias on overall mortality is ac-centuated in populations with longer life expectancy, in part related to elevated rates of cancer. The majority of human malignancies exhibit a sex bias with elevated frequencies in males...
April 22, 2024: Molecular Cancer Research: MCR
https://read.qxmd.com/read/38647152/eravacycline-an-antibacterial-drug-repurposed-for-pancreatic-cancer-therapy-insights-from-a-molecular-based-deep-learning-model
#19
JOURNAL ARTICLE
Adi Jabarin, Guy Shtar, Valeria Feinshtein, Eyal Mazuz, Bracha Shapira, Shimon Ben-Shabat, Lior Rokach
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) remains a serious threat to health, with limited effective therapeutic options, especially due to advanced stage at diagnosis and its inherent resistance to chemotherapy, making it one of the leading causes of cancer-related deaths worldwide. The lack of clear treatment directions underscores the urgent need for innovative approaches to address and manage this deadly condition. In this research, we repurpose drugs with potential anti-cancer activity using machine learning (ML)...
March 27, 2024: Briefings in Bioinformatics
https://read.qxmd.com/read/38646652/theranostics-and-artificial-intelligence-new-frontiers-in-personalized-medicine
#20
REVIEW
Gokce Belge Bilgin, Cem Bilgin, Brian J Burkett, Jacob J Orme, Daniel S Childs, Matthew P Thorpe, Thorvardur R Halfdanarson, Geoffrey B Johnson, Ayse Tuba Kendi, Oliver Sartor
The field of theranostics is rapidly advancing, driven by the goals of enhancing patient care. Recent breakthroughs in artificial intelligence (AI) and its innovative theranostic applications have marked a critical step forward in nuclear medicine, leading to a significant paradigm shift in precision oncology. For instance, AI-assisted tumor characterization, including automated image interpretation, tumor segmentation, feature identification, and prediction of high-risk lesions, improves diagnostic processes, offering a precise and detailed evaluation...
2024: Theranostics
keyword
keyword
160938
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.